左心室合指数预测急性心肌梗塞的预后不佳:单中心队列研究
Chuyun Chen1, Haolei Huang1, Jia Jia1,2
1Department of Cardiology, Peking University First Hospital, Beijing 100034, China.
Journal of cardiovascular development and disease
|February 26, 2026
概括
新的左心室合指数 (LACI) 预测急性心肌梗塞 (AMI) 患者的治疗结果不佳. 较高的LACI水平与重大心血管不良事件 (MACE) 的风险增加有关,有助于二次预防策略.
科学领域:
- 心脏病学 心脏病学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
- 临床研究 临床研究
背景情况:
- 左心室合指数 (LACI) 是评估心脏功能的新参数.
- 在急性心肌梗塞 (AMI) 患者中,其与主要不良心血管事件 (MACE) 的关联需要进一步调查.
研究的目的:
- 在AMI患者中评估LACI和MACE之间的关联.
- 确定LACI在二次预防风险分层中的有用性.
主要方法:
- 对843名AMI患者进行了回顾性队列研究.
- 在接受LACI测量的入院时进行的胸外心声扫描.
- 随访时间中位数为4.31年,MACE作为主要终点.
主要成果:
- 中位数LACI为0.24;17.91%的患者经历了MACE.
- 风险分层的最佳LACI截止值被确定为0.257.
- 在多变量调整后,增加的LACI与更高的MACE风险,全因死亡,心血管死亡和中风相关.
结论:
- LACI是AMI患者预后不佳的独立预测因素.
- 在二次预防策略中,LACI可以成为一个有价值的风险分层工具.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
334
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
334
Acute Coronary Syndrome I: Introduction
1.2K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
535
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
535
Heart Failure IV: Classification and Diagnostic Evaluation
476
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
476
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Coronary Artery Disease II: Pathophysiology
810
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
810


